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Concise Communication

Variability of surgical prophylaxis in penicillin-allergic children
David F. Butler MD1,†, Brian R. Lee MPH, PhD1, Sarah Suppes PharmD2, Tracy Sandritter PharmD2,
Jason G. Newland MD, M.Ed3, Lory Harte PharmD2 and Jennifer L. Goldman MD, MS1
1
3

Department of Pediatrics, Children’s Mercy Hospital, Kansas City, Missouri, 2Department of Pharmacy, Children’s Mercy Hospital, Kansas City, Missouri and
Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri

Abstract
We retrospectively evaluated the effect of penicillin adverse drug reaction (ADR) labeling on surgical antibiotic prophylaxis. Cefazolin was
administered in 86% of penicillin ADR-negative (− ) and 28% penicillin ADR-positive ( + ) cases. Broad-spectrum antibiotic use was more
common in ADR( + ) cases and was more commonly associated with perioperative adverse drug events.
(Received 21 March 2018; accepted 19 August 2018)

Approximately 10% of patients have a documented penicillin
allergy, although the incidence of a true allergic reaction is much
less frequent.1 A penicillin adverse drug reaction (ADR) label is
associated with the unnecessary use of broad-spectrum antibiotics, prolonged hospitalization, increased prevalence of
multidrug-resistant infections, and increased risk of death compared to those without a penicillin ADR label.2–4 ADRs may refer
to allergic reactions (eg, rash or anaphylaxis) or side effects (eg,
diarrhea). Unfortunately, clinicians often fail to obtain a thorough
ADR history or to clarify the type of reported reaction prior to
prescribing medication.2,3
Antibiotic prophylaxis is utilized routinely to reduce the risk of
surgical site infections (SSIs) in high-risk pediatric procedures.5,6
Cefazolin is the drug of choice for many procedures because it is
bactericidal, rapidly infused/distributed, and covers skin pathogens such as Staphylococcus aureus associated with SSIs.5,6 While
structurally similar to penicillin due to the β-lactam ring, different
side chains result in minimal cross reactivity. Only patients who
experience an IgE-mediated response (eg, anaphylaxis) or a severe
cutaneous reaction (eg, Stevens-Johnson syndrome) to penicillin
should avoid future cephalosporins.5 The primary objective of our
study was to determine antibiotic prophylaxis selection in
pediatric surgical patients with a documented penicillin ADR.
Secondarily, we aimed to determine the antibiotic prophylaxis
most commonly associated with perioperative adverse drug
events (ADEs).
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Materials and methods
Population and setting
A retrospective study was performed extracting data from a surgical
bundle reliability report for the period from January 1, 2011, to
December 31, 2013. The surgical bundle reliability report is generated from the hospital electronic medical records as a part of a
national quality improvement collaborative. All operating room
procedures lasting >5 minutes are included in the report. For this
study, only patients who received at least 1 dose of an intraoperative
antibiotic were included. The data collected included age, race,
gender, surgery month/year, surgical procedure, isolation status (ie,
evidence of methicillin-resistant S. aureus (MRSA) carrier status),
wound class (ie, clean, clean/contaminated, contaminated, dirty/
infected), and antibiotic(s) administered during surgery. The Children’s Mercy Institutional Review Board approved this protocol.
Penicillin ADR label
Penicillin ADR type was defined as allergy or hypersensitivity or
side effect, and severity was defined as follows: mild, implicated
drug continued; moderate, implicated drug discontinued and/or
ADR treatment required; and severe, life-threatening or need for
hospitalization. ADR type and severity data were available in the
electronic medical record (EMR) at the time of surgery. These
data are readily available to prescribers; however, attention to this
qualifier is user dependent and likely variable. Documentation of
penicillin ADRs included any of the following antibiotics:
amoxicillin, oxacillin, penicillin, amoxicillin-clavulanate, ampicillin, ampicillin-sulbactam, piperacillin-tazobactam. Patients
with a penicillin allergy or hypersensitivity but undocumented
severity were included as ‘unknown’ severity. Patients with a
documented cephalosporin ADR were excluded.
Potential perioperative adverse drug event (ADE)
Potential perioperative ADEs were based on International Classification of Diseases, Ninth Revision, Clinical Modification
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(ICD-9-CM) diagnostic codes (Table 1). ADE codes were selected
from an extensive list of the National Expert Panel of the ICD-9CM Adverse Event Classification, Utah/Missouri Patient Safety
Consortium and from codes used by our active hospital pharmacovigilance program to identify ADEs.7,8 Those codes considered pertinent to antibiotic-associated ADEs were included.
Patients who had an ADE-associated ICD-9 code or E-code at
either the point of discharge following the initial surgical procedure or during a subsequent hospitalization (if readmission
occurred within 48 hours of the initial surgical procedure) were
considered to have potentially experienced a perioperative ADE.
Data analysis
The association of penicillin ADR status with intraoperative
antibiotic selection and perioperative ADEs was determined using
categorical analysis; the Fisher exact test was used to determine
statistical significance. A multivariable logit model was developed
to determine the odds of receiving a drug other than cefazolin,
adjusting for MRSA isolation and surgical wound class. All analyses were completed using Stata version 14 software (StataCorp,
College Station, TX).

Results
In total, 17,741 operations with intraoperative AP were identified.
We excluded 382 operations (2.2%) due to a documented
cephalosporin allergy. These patients were predominately
male (56%) and white (69%), with a median age of 7.6 years

Table 1. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Codes Used to Identify Perioperative Adverse Drug Effects
ICD-9-CM

a
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(interquartile range [IQR], 2.3–13.4). Most wounds were classified
as clean (66%) or clean-contaminated (28%). The most common
procedures were closed reduction of the elbow with percutaneous
pinning, removal of hardware, and laparoscopic-assisted gastrostomy. A penicillin ADR label (allergy or hypersensitivity or side
effect) was documented in 1,150 cases (6.6%). The prevalence of
cefazolin administration in ADR negative ( − ) cases was significantly higher (86%) compared to ADR positive ( + ) allergy or
hypersensitivity cases (28%; P < .001) or ADR( + ) side-effect
cases (48%; P < .001). After adjusting for MRSA isolation and
wound class, the odds of receiving an alternative agent compared
to ADR( − ) cases, was significantly higher in ADR( + ) allergy or
hypersensitivity cases (25.4; 95% confidence interval [CI], 21.8–
29.6) and ADR( + ) side-effect cases (6.4; 95% CI, 3.8–11.0).
Penicillin ADR severity had no effect on the likelihood of
receiving an alternative to cefazolin.
Clindamycin was the most commonly prescribed alternative
antibiotic prophylaxis among ADR( + ) patients at 58.4%. This
was significantly higher compared to ADR( − ) patients (5.3%;
P < .001). Penicillin ADR( + ) patients also received gentamicin
(4% vs 0.1%; P < .001) and vancomycin more frequently (2.8% vs
0.7%; P < .001) compared to ADR( − ) patients (Fig. 1).
In total, 137 perioperative ADEs were identified, the most
common were skin eruption, documented in 59 cases (43%),
allergic urticaria (N = 10; 7.3%), and drug dermatitis (N = 9;
6.6%). When cefazolin was administered, there was no difference
in the perioperative ADE rate between penicillin ADR( + ) allergy
or hypersensitivity and ADR( − ) patients (1.04% vs 0.75%,
respectively; P = 0.485). Overall, vancomycin was the antibiotic
most commonly associated with a perioperative ADE, occurring
in 3.3% of all cases. Penicillin ADR( + ) patients experienced
perioperative ADEs to vancomycin (9.7%), noncefazolin cephalosporins (5.1%), and clindamycin (0.77%).

Description

283.9

Acquired hemolytic anemia

Discussion

288.03

Drug induced neutropenia

693.0

Drug dermatitis

695.1

Erythema multiforme

708.0

Allergic urticaria

708.9

Urticaria nosa

782.1

Nonspecific skin eruption

995

Other anaphylactic reaction

995.1

Angioneurotic edema

995.2

Unspecified adverse effect of unspecified drug, medicinal
and biological substance

995.27

Other drug allergy

995.3

Allergy, unspecified

e94.60

Local anti-infectives and anti-inflammatory drugs causing
adverse effects in therapeutic use

960–961,
E856–857

Poisoning by antibiotics and other anti-infectives

E930–E931

Adverse effects of antibiotics and other anti-infectives

Surgical antibiotic prophylaxis results in significant antibiotic
exposure among children.6,9 Despite evidence that cefazolin is
safe to use in children with a non–life-threatening penicillin ADR
history, many clinicians remain reluctant. Ideally, cefazolin would
be selected when indicated because it is narrow-spectrum and
well tolerated and has been extensively studied. Our results
demonstrate that prescribers avoid cefazolin in children labeled
with a penicillin ADR, regardless of the severity of the reaction.
Additionally, alternative antibiotics such as vancomycin were
associated with higher rates of perioperative ADRs compared to
cefazolin.
In this study, penicillin ADR( + ) patients received an alternative agent instead of cefazolin in 72% of cases. This is consistent
with Beltran et al9 who reported that ADR( + ) children received
cefazolin in only 20% of cases. We observed that penicillin ADR
classification and severity did not influence antibiotic choice,
suggesting that providers are not relying on ADR history to guide
antibiotic selection. Clindamycin was the most common cefazolin
alternative selected. Unfortunately, clindamycin has limitations
due to rising resistance, making it potentially ineffective against
methicillin-susceptible S. aureus for which cefazolin would be
100% effective.10
Only 1% of penicillin ADR( + ) patients who received cefazolin
experienced a perioperative ADE, which is consistent with previous findings.9 Our data reveal that perioperative ADEs occurred

Not otherwise specified.
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Fig. 1. Antibiotic prophylaxis exposure based on penicillin allergy classification and associated perioperative adverse drug reactions (ADR).

more frequently in ADR( + ) patients who received vancomycin
or alternative cephalosporins. Thus, data also highlight the finding that cefazolin alternatives are associated with a potential
increased risk for perioperative ADEs.
Our study has several limitations. The findings are limited to a
single pediatric institution and therefore may not be generalizable.
This study was retrospective in nature, and perioperative ADEs
were documented based on ICD-9-CM and E codes. Conversely,
ICD-9-CM and E codes have proven effective in identifying ADEs
in hospitalized patients, including surgical patients.11,12 The
selected codes were likely not all-inclusive for antibiotic-associated
ADEs and could have resulted in an underrepresentation of
ADEs. Attributing a perioperative ADE specifically to an antibiotic is difficult without subsequent drug rechallenge or skin
testing. Most of the documented penicillin ADRs were unknown
in severity, which made it challenging to determine whether
cefazolin would be indicated using ADR label alone. Notably, a
review of the surgical procedures included in our study’s patient
population revealed that many do not routinely require antibiotic
prophylaxis (ie, circumcision, tympanoplasty). This finding
highlights the lack of standardization for routine antibiotic prophylaxis and demonstrates that additional work is needed to limit
antibiotic exposure and ADE risk for procedures without prophylaxis indications. Regardless, our data strongly indicate that
perioperative antibiotic prescribing is highly variable among
children with a documented penicillin ADR. Further research is
needed to optimize clarification and interpretation of an ADR
history to safely standardize care, to provide the antibiotic of
choice when possible, and to utilize a safe alternative when truly
needed.
In conclusion, our study demonstrates that surgical AP varies
significantly in children with documented penicillin ADRs
resulting in the unnecessary use of alternative antibiotics that
result in higher rates of perioperative ADEs. Further work is
needed to standardize AP selection in those labeled penicillin

allergic and minimize the avoidance of cefazolin in cases when it
can be safely administered.
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